Introduction      |       Products       |      Applications       |       Partnering       |       Events    

News May 2016: ​​GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma                                        More >>

GlycoSeLect Ltd Completes 450K Seed Funding Round

News August 2016: ​​GSL UK  Announces Establishment of a New Research Laboratory in South Tees Bio-Incubator                   More >>

News Jan 2017: Silicon Republic - Innovation: GlycoSeLect Listed as One of "10 Marvellous Medtec Start-Ups You Need to Know" ​​More >>               

KBI BioPharma Inc. and Enterprise Ireland Invest in Irish Biotechnology Separations Company, GlycoSeLect Ltd., to Complete its Seed Funding Round

Latest News: October 24th 2017

RPLs present many Advantages over existing analytical and purification tools. RPL production is also readily scalable enabling their use for all application scales.

RPLs are enhanced glycoselective bioaffinity proteins that enable efficient detection, analysis and selective isolation of glycosylated biomolecules. Applications

GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs). 


       Introduction     |        Products        |      Applications      |        Partnering       |      Events 

Recombinant Prokaryotic Lectins